Melissa B. Epperly, Director at Roivant Sciences Ltd. (ROIV), sold 17,750 shares at $34.32 ($610K) on 2026-06-29, disclosed to the SEC on 2026-07-01.
Seasonal sale ($610k) by Director — this insider has traded ROIV in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.32 | 15,002 | $515K | 84.4% |
| 2 | $34.71 | 2,748 | $95K | 15.6% |
| Total | $34.38 avg | 17,750 | $610K | 100% |
| Filing → |
| ROIV | SELL | 2026-03-18 | $1.2M | — | Filing → |
| ZNTL | SELL | 2024-02-12 | $29K | — | Filing → |
| ZNTL | SELL | 2024-02-05 | $200K | — | Filing → |